Drawing for PERFECTPRO

USPTO serial 77967277

PERFECTPRO

Reviewed by CopyMark Law Group

Reg. 4091572Status 710
Filing date
Status date
Registration date
Jan 24, 2012
Examiner
MARTIN, EUGENIA K
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PERFECTPRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Barry L. Kelmachter

BARRY L. KELMACHTER BACHMAN & LAPOINTE, P.C.900 CHAPEL ST STE 1201NEW HAVEN, CT 06510-2889UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents not for human medical and veterinary purposes, in particular for scientific research and for medical laboratory use for sample preparation, modification and manipulation of cells and for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, particularly nucleic acids, proteins, macromolecules and biologically active substances; kits for scientific research and for medical laboratory use consisting primarily of siRNA compounds, protein assays and chemical reagents all sold as a unit in particular for sample preparation, modification and manipulation of cells and for labeling, separation, isolation, reproduction and purification of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological materialSECTION 8 - CANCELLEDAug 1, 2007
005Products for human medicine and veterinary medicine purposes, namely, for medical diagnostic purposes, consisting of diagnostic preparations for sample preparation, modification, and manipulation of cells and for labeling, separation, isolation, reproduction and purification of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances; chemical, biochemical, and biotechnological products all for human medicine and veterinary medicine purposes, namely, for medical diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits for medical diagnostic purposes consisting primarily of siRNA compounds, protein assays and chemical reagents for human medicine or veterinary medicine diagnostic purposes, all sold as a unit, for sample preparation, modification and manipulation of cells and for labeling, separations, isolation, reproduction and purification of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids and proteins from biological materialSECTION 8 - CANCELLEDAug 1, 2007
009Scientific apparatuses, instruments and equipment, namely, optical emission spectrometers, atomic absorption spectrometers and X-ray machines, other than for medical use; optical inspection apparatus for industrial use; chemical detection system comprising strobe and probe lasers, optical detectors; calculating machines, electrical and electronic apparatuses and instruments, namely, computer-controlled electronic machines for electrophysiological measurements and testing of cells and fluid samples for research and analysis purposes, and laboratory equipment, namely, chromatography apparatus for laboratory use; measuring apparatus and instruments, namely, laboratory robot manipulators designed to move, handle, and process samples, laboratory consumable dispensers for the transfer of fluids, live cells and fluid samples, laboratory sample conditioners, namely, incubators, stirrers for stirring fluids, solutions and fluid samples, mixers for mixing fluids, solutions and fluid samples, dispensers for the transfer of fluids, live cells and fluid samples, aspirators for fluids and fluid samples, filter systems for laboratory purposes for filtering fluids, ultrafiltration devices and apparatuses for detection, concentration, separation and purification of biological samples, ultrafiltration membranes for filtration of biological samples, chromatography apparatuses and instruments, namely, chromatography apparatus for laboratory use, ion exchanger apparatuses and instruments, namely, automatic ion-exchange chromatography apparatus for laboratory use, laboratory concentrator devices for concentrating fluid samples, scientific apparatuses and instruments being laboratory equipment and single use laboratory articles, namely, laboratory apparatuses for the processing of fluid samples, namely, apparatuses for dosing, transferring, mixing, tempering, concentrating, homogenizing and filtering of sample liquids and reagents for medical and veterinary medical diagnostic purposes, namely, for use in sample preparation, modification and manipulation of cells and for labeling, separation, isolation, reproduction and the purification of biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids and proteins from biological materialSECTION 8 - CANCELLEDAug 1, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 31, 2018C8..CANCELLED SEC. 8 (6-YR)—
Jan 24, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 24, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 20, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 17, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Dec 12, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 11, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 11, 2011AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 6, 2011IUAFUSE AMENDMENT FILED—
Oct 6, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 26, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 1, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 1, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 27, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 25, 2011ALIEASSIGNED TO LIE—
Dec 23, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 20, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 20, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2010DOCKASSIGNED TO EXAMINER—
Mar 30, 2010MPMKNOTICE OF PSEUDO MARK MAILED—
Mar 29, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 27, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance